ClarificationJul 22, 2026, 04:46 PM
Biofrontera Amends 10-K for Exhibit Index & Certifications
AI Summary
Biofrontera Inc. has filed an Amendment No. 1 to its Annual Report on Form 10-K for the fiscal year ended December 31, 2025. This amendment primarily serves to include Exhibit 3.3 in the exhibit index and implement other minor adjustments to the index. Additionally, it incorporates new certifications from the company's principal executive and financial officers, as mandated by Section 302 of the Sarbanes-Oxley Act of 2002.
Key Highlights
- Biofrontera Inc. filed an Amendment No. 1 to its Annual Report on Form 10-K for fiscal year ended December 31, 2025.
- The amendment solely includes Exhibit 3.3 in the exhibit index and makes other minor changes to the index.
- New certifications from the Principal Executive Officer and Principal Financial Officer are included as required by Section 302 of Sarbanes-Oxley Act.
- Paragraphs 3, 4, and 5 of the certifications were omitted as no financial statements are included in this amendment.
- The Form 10-K/A does not modify or update the Original 10-K beyond the stated changes.
Price Impact
More from BFRI